188 related articles for article (PubMed ID: 22421772)
1. [A case of adenocarcinoma of the lung with malignant pleural effusion in elderly patient treated effectively by pemetrexed and carboplatin].
Tada A; Sakaguchi K; Kobayashi M; Kagoshima T; Yamazaki Y; Kamisawa O
Gan To Kagaku Ryoho; 2012 Mar; 39(3):425-7. PubMed ID: 22421772
[TBL] [Abstract][Full Text] [Related]
2. [A case of lung cancer in an elderly patient with malignant pleural effusion and pneumothorax treated with carboplatin, pemetrexed, and bevacizumab].
Miyahara E; Itagaki T; Kuwahara M; Kameda A; Oue N
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1237-40. PubMed ID: 25335706
[TBL] [Abstract][Full Text] [Related]
3. [A case of Carboplatin and pemetrexed combination chemotherapy for synchronous double cancers of hepatocellular carcinoma and primary lung cancer].
Okamoto E; Sato J; Sema M; Hayasaka J; Watanabe A; Takagi K; Kusano-Kitazume A; Tamura A; Kondo M; Sakuranaka H; Ochi J; Hanada S; Tanaka M; Akita H; Tei S; Ichioka M; Shibayama T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2154-6. PubMed ID: 25731454
[TBL] [Abstract][Full Text] [Related]
4. Third-space fluid distribution of pemetrexed in non-small cell lung cancer patients.
Honoré PH; Joensen SJ; Olsen M; Hansen SH; Mellemgaard A
Cancer Chemother Pharmacol; 2014 Aug; 74(2):349-57. PubMed ID: 24934863
[TBL] [Abstract][Full Text] [Related]
5. [Case of pemetrexed-induced acute lung injury].
Sakamoto S; Kaburaki K; Sakaguchi S; Sano G; Sugino K; Isobe K; Shibuya K; Kurosaki A; Uekusa T; Homma S
Nihon Kokyuki Gakkai Zasshi; 2009 May; 47(5):415-20. PubMed ID: 19514505
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of malignant effusion treated successfully by loco-regional administration of carboplatin].
Takahashi J; Kinomura S; Abe Y; Yoshioka S; Yambe T; Ono S; Ito H; Fukuda H; Yamada K; Sato T
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2817-20. PubMed ID: 7993120
[TBL] [Abstract][Full Text] [Related]
7. [A case of lung cancer showing marked reduction of pleural effusion by bevacizumab in combination with carboplatin and paclitaxel].
Hama M; Komatsu Y; Hachiya T
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1877-9. PubMed ID: 22083202
[TBL] [Abstract][Full Text] [Related]
8. [Primary lateral sclerosis and lung adenocarcinoma].
Martinez L; Lamaze R; Clément-Duchêne C
Rev Mal Respir; 2013 Mar; 30(3):227-30. PubMed ID: 23497933
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of recurrent invasive mucinous adenocarcinoma of the lung showing marked responses to platinum-based chemotherapyregimens with pemetrexed and bevacizumab].
Koma Y; Nakashima N; Koyama M; Goto K; Yokota N; Kimura K; Matsumoto Y; Yoshida C; Matsuoka H; Masuya D; Yoshimatsu H; Suzuki Y
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1525-8. PubMed ID: 24231707
[TBL] [Abstract][Full Text] [Related]
10. [Long-term survival of patient with brain metastases from lung cancer treated by pemetrexed monotherapy].
Ito S; Ogawa Y; Harada H; Yamaguchi T; Munakata K
Gan To Kagaku Ryoho; 2012 May; 39(5):793-6. PubMed ID: 22584333
[TBL] [Abstract][Full Text] [Related]
11. A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer.
Rodrigues-Pereira J; Kim JH; Magallanes M; Lee DH; Wang J; Ganju V; Martínez-Barrera L; Barraclough H; van Kooten M; Orlando M
J Thorac Oncol; 2011 Nov; 6(11):1907-14. PubMed ID: 22005471
[TBL] [Abstract][Full Text] [Related]
12. EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy.
Guo H; Wan Y; Tian G; Liu Q; Kang Y; Li Y; Yao Z; Lin D
Oncol Rep; 2012 Mar; 27(3):880-90. PubMed ID: 22134479
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A.
Usui K; Sugawara S; Nishitsuji M; Fujita Y; Inoue A; Mouri A; Watanabe H; Sakai H; Kinoshita I; Ohhara Y; Maemondo M; Kagamu H; Hagiwara K; Kobayashi K;
Lung Cancer; 2016 Sep; 99():131-6. PubMed ID: 27565928
[TBL] [Abstract][Full Text] [Related]
14. [A case of cardiac tamponade due to malignant pericarditis with lung adenocarcinoma, effectively treated with pericardial drainage and pemetrexed plus cisplatin chemotherapy].
Yoshida K; Teramoto S
Nihon Ronen Igakkai Zasshi; 2015; 52(4):421-4. PubMed ID: 26700783
[TBL] [Abstract][Full Text] [Related]
15. Massive malignant pleural effusion due to lung adenocarcinoma in 13-year-old boy.
Afghani R; Hajimohammadi A; Azarhoush R; Kazemi-Nejad V; Yari B; Rezapour Esfahani M
Asian Cardiovasc Thorac Ann; 2016 May; 24(4):389-92. PubMed ID: 26857800
[TBL] [Abstract][Full Text] [Related]
16. Dose escalation and pharmacokinetic study of carboplatin plus pemetrexed for elderly patients with advanced nonsquamous non-small-cell lung cancer: Kumamoto thoracic oncology study group trial 1002.
Sakata S; Sasaki J; Saeki S; Hamada A; Kishi H; Nakamura K; Tanaka H; Notsute D; Sato R; Saruwatari K; Iriki T; Akaike K; Fujii S; Hirosako S; Kohrogi H
Oncology; 2015; 88(4):201-7. PubMed ID: 25502447
[TBL] [Abstract][Full Text] [Related]
17. Percentage Change in Plasma Cytokeratin 18 Is Associated with Clinical Outcomes in Patients Receiving Pemetrexed and Carboplatin for the Adenocarcinoma Subtype of NSCLC.
Strimpakos AS; Banerji U; Thavasu P; Tsilimagou A; Psyrri A; Syrigos KN
Oncology; 2015; 89(1):53-9. PubMed ID: 25766505
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience of the use of pemetrexed (PEM) combined with cisplatin (CDDP)/Carboplatin (CBDCA) followed by long-term maintenance PEM in patients with non-squamous non-small cell lung cancer].
Ishikura H; Kumihashi Y; Kimura S; Matsuoka Y; Matsumoto D
Gan To Kagaku Ryoho; 2014 May; 41(5):623-6. PubMed ID: 24917009
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of endostar combined with cisplatin/ pemetrexed chemotherapy for elderly patients with advanced malignant pleural effusion of lung adenocarcinoma.
Jie Wang X; Miao K; Luo Y; Li R; Shou T; Wang P; Li X
J BUON; 2018; 23(1):92-97. PubMed ID: 29552766
[TBL] [Abstract][Full Text] [Related]
20. Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer.
Socinski MA; Raju RN; Stinchcombe T; Kocs DM; Couch LS; Barrera D; Rousey SR; Choksi JK; Jotte R; Patt DA; Periman PO; Schlossberg HR; Weissman CH; Wang Y; Asmar L; Pritchard S; Bromund J; Peng G; Treat J; Obasaju CK
J Thorac Oncol; 2010 Dec; 5(12):1963-9. PubMed ID: 21102260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
